Dr. Chul Kim
Claim this profileMedStar Georgetown University Hospital
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
11 reported clinical trials
17 drugs studied
Area of expertise
1Lung Cancer
Stage IV
Stage III
Stage II
2Non-Small Cell Lung Cancer
Stage IV
Stage III
Stage II
Affiliated Hospitals
Clinical Trials Chul Kim is currently running
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
Sacituzumab Govitecan
for Thymic Cancer
The goal of this clinical trial is to study the effect of sacituzumab govitecan-hziy in adult patients with advanced thymoma and thymic carcinoma after progressing on at least one prior line of therapy. The main question it aims to answer is: • What is the overall response rate (ORR) in patients with advanced thymoma and thymic carcinoma? Participants will: * receive a fixed dose of 10 mg/kg given intravenously, once weekly on Days 1 and 8 of continuous 21-day treatment cycles until disease progression or unacceptable toxicity * have regular blood tests, scans, and examinations to monitor their health. * have blood and a biopsy of their tumor for research purposes.
Recruiting1 award Phase 2
More about Chul Kim
Clinical Trial Related2 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 9 Active Clinical TrialsTreatments Chul Kim has experience with
- LYL797
- Durvalumab
- Tremelimumab
- Platinum-based Chemotherapy
- Sacituzumab Govitecan
- MGC018
Breakdown of trials Chul Kim has run
Lung Cancer
Non-Small Cell Lung Cancer
Skin Cancer
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Chul Kim specialize in?
Chul Kim focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Chul Kim currently recruiting for clinical trials?
Yes, Chul Kim is currently recruiting for 9 clinical trials in Washington District of Columbia. If you're interested in participating, you should apply.
Are there any treatments that Chul Kim has studied deeply?
Yes, Chul Kim has studied treatments such as LYL797, Durvalumab, Tremelimumab.
What is the best way to schedule an appointment with Chul Kim?
Apply for one of the trials that Chul Kim is conducting.
What is the office address of Chul Kim?
The office of Chul Kim is located at: MedStar Georgetown University Hospital, Washington, District of Columbia 20007 United States. This is the address for their practice at the MedStar Georgetown University Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.